Searched for
IVD MARKET IN INDIA
Warburg, Bain, CVC among PE firms in talks to buy into Agappe DiagnosticsSeveral global private equity firms are exploring a significant stake purchase in Agappe Diagnostics. This potential deal involves both exi...- Avience Biomedicals IPO: Check GMP, price band and other detailsThe grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...
- 620% rally makes Cupid the costliest stock in its category at 197 P/E. Should investors be cautious?Cupid, a contraceptives manufacturer, has seen a remarkable 620% rally in the past year, making it the costliest stock in its category with...
- Lord’s Mark among few global players to win HIV self-test approval, exports from June 2026Lord's Mark Industries Ltd. has secured Central Licensing Authority approval for its LordsMed HIV 1&2 Self Test, becoming one of nine globa...
- Cupid shares plunge 20% on profit booking, end 13-session unbeaten rallyCupid shares fell sharply on Fridat after a 13-session unbeaten rally, driven by heavy profit booking and strong volumes. The stock, which ...
- India weighs lower tariffs for US medical devices amid trade talksThe Indian government is considering lowering tariffs on US medical devices to mitigate potential US tariff threats on Indian exports. Whil...
- India denies clinical trial waivers for In-vitro diagnostics despite global approvalsIndia's Drugs Technical Advisory Board decides against waiving clinical trials for In-vitro Diagnostics despite their approval in other cou...
- India reverses old trend in medical consumables business, is now a net exporterTill now, foreign-sourced goods used to dominate the medical consumables and disposables market in the country. In the fiscal year 2022-23,...
- Cupid Q4 Results: Net profit increases 184% YoY to Rs 24 croreFor the full year, net profit rose 26% to Rs 39.85 crore against Rs 31.58 crore during the previous fiscal.
- Rules of origin for medical devices sector remains a sticking point under India-UK proposed FTA"In the medical devices sector, a lot of issues related to rules of origin are still there. Demand for customs duty concessions is also the...
- Universal-Halwasiya Group to make Rs 113-crore open offer to acquire 26% in condom maker CupidThe open offer follows Universal-Halwasiya Group and Family through Columbia Petro Chem Private Limited and Halwasiya, entering into a defi...
- LordsMed enters into distribution partnership with Hindustan Antibiotics LimitedThe healthcare company will manufacture high-quality rapid antigen test kits at its ICMR approved GMP and ISO certified facility at Vasai, ...
- LordsMed launches IVD manufacturing facility at near MumbaiSpread over 20,000 sq ft area, the IVD manufacturing facility is equipped with state-of-the-art technologies and infrastructure of global s...
- Roche Diagnostics appoints Narendra Varde as MD India & Neighbouring MarketsRoche Diagnostics India, a part of the Roche Group, on Wednesday announced the appointment of Narendra Varde as Managing Director for India...
- Local players keen to fill the China void, manufacture testing kitsDomestic manufacturers of rapid antibody rapid test kits for novel coronavirus have approached the Indian Council of Medical Research (ICMR...
- Roche Diagnostics India looks at 15 per cent IVD market share in 2 yearsRoche Diagnostics is part of Swiss healthcare major Roche. It sells devices and equipment to labs and hospitals and is mainly present in th...
- Trivitron buys 60 per cent stake in Turkish firm for 5 million eurosTrivitron Chairman and Managing Director G S K Velu said: "We have invested 5 million euros for picking up the stake including share premiu...
- Agappe Diagnostic Ltd targetting tier 2 and 3 marketsAgappe Diagnostic Limited is planning to tap the tier 2 and 3 markets by expanding its production capacities.
- Arkray to buy Span IVD unit for Rs 100 crArkray has entered into an agreement to buy out the in-vitro diagnostics business of Surat-based Span Diagnostics for close to Rs 100 crore.
- Trivitron, BioSystems, Spain to set up facility in ChennaiMedical technology company Trivitron has forged an alliance with BioSystems of Spain to manufacture IVD Reagents.
Load More
